Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains | Zendy

Mingju Hao | Zendy; Jessica A. Schuyler | Zendy; Haifang Zhang | Zendy; Elena Shashkina | Zendy; Hong Du | Zendy; Derrick E. Fouts | Zendy; Michael J. Satlin | Zendy; Barry N. Kreiswirth | Zendy; Liang Chen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains

Author(s) -

Mingju Hao,

Jessica A. Schuyler,

Haifang Zhang,

Elena Shashkina,

Hong Du,

Derrick E. Fouts,

Michael J. Satlin,

Barry N. Kreiswirth,

Liang Chen

Publication year - 2021

Publication title -

journal of antimicrobial chemotherapy

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkab131

Subject(s) - klebsiella pneumoniae , microbiology and biotechnology , plasmid , multilocus sequence typing , broth microdilution , antibiotic resistance , biology , antibiotics , escherichia coli , gene , genotype , minimum inhibitory concentration , genetics

Recent studies indicated that the monosubstituted deoxystreptamine aminoglycoside apramycin is a potent antibiotic against a wide range of MDR Gram-negative pathogens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research